OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Dermapharm Holding SE/  DE000A2GS5D8  /

Cboe Europe DXE
2024-04-19  5:29:52 PM Chg. -0.05 Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
31.90EUR -0.16% 2,941
Turnover: 52,955.43		 -Bid Size: - -Ask Size: - 1.73 bill.EUR 2.74% 27.67

Assets

 2019
-
in mill. EUR		 2020
-
in mill. EUR		 2021
-
in mill. EUR		 2022
IFRS
in mill. EUR		 2023
IFRS
in mill. EUR
Property and Equipment
  132.6000   199.6000   222.3000   225.7000   330.7700
Intangible Assets
  293   297.3000   294.8000   305   544.8600
Long-Term Investments
  -   -   -   -   23.6000
Fixed Assets
  -   -   -   878.9000   1,530.1700
Inventories
  175.6000   205.7000   243.6000   255.7000   320.7500
Accounts Receivable
  -   -   -   96.7000   90.9300
Cash and Cash Equivalents
  115   120.3000   161.4000   151   158.7200
Current Assets
  352.9000   400.1000   519.2000   533.9000   630.4900
Total Assets
  1,044.9000   1,224.4000   1,407   1,412.8000   2,160.6700

 

Liabilities

 2019
-
in mill. EUR		 2020
-
in mill. EUR		 2021
-
in mill. EUR		 2022
IFRS
in mill. EUR		 2023
IFRS
in mill. EUR
Accounts Payable
  35.4000   50.4000   52.1000   56.1000   86.6400
Long-term debt
  562   581.1000   574.7000   511.6000   963.9500
Liabilities to Banks
  580.4000   607.1000   581.1000   -   -
Provisions
  49.1000   62.6000   103.6000   164.7000   256.9000
Liabilities
  760.4000   899.8000   907.1000   880.4000   1,615.5100
Share Capital
  53.8400   53.8400   53.8400   -   -
Total Equity
  284.5000   324.6000   499.8000   531.6000   539.2000
Minority Interests
  5.8000   2.6000   2.5000   .9000   5.8400
Total liabilities equity
  1,044.9000   1,224.4000   1,407   1,412.8000   2,160.6700

 

Income Statement

 2019
-
in mill. EUR		 2020
-
in mill. EUR		 2021
-
in mill. EUR		 2022
IFRS
in mill. EUR		 2023
IFRS
in mill. EUR
Revenues
  701   793.8000   942.9000   1,024.8000   1,135.3500
Depreciation (total)
  50.1000   49.2000   55.6000   101.2000   104.5800
Operating Result
  119.5000   136.9000   298.5000   243.7000   182.8900
Interest Income
  -8.4000   -10   -5.8000   -13.8000   -69.7400
Income Before Taxes
  110.1000   125.3000   293   -   -
Income Taxes
  32.3000   39.4000   84.1000   134.2000   45.4600
Minority Interests Profit
  0.0000   0.0000   0.0000   -1.7000   1.8300
Net Income
  77.8000   85.9000   208.9000   132.6000   58.1100

 

Per Share

 2019
-
in EUR		 2020
-
in EUR		 2021
-
in EUR		 2022
IFRS
in EUR		 2023
IFRS
in EUR
Earnings per Share
  1.4300   1.5900   3.8900   2.4900   1.1600
Dividend per Share
  0.8000   0.8800   2.1700   1.0500   0.8800

 

Cash Flow

 2019
-
in mill. EUR		 2020
-
in mill. EUR		 2021
-
in mill. EUR		 2022
IFRS
in mill. EUR		 2023
IFRS
in mill. EUR
Cash Flow from Operating Activities
  100.6000   131.1000   250.4000   288.5000   219.4200
Cash Flow from Investing Activities
  -382.2000   -105.9000   -129.3000   -99   -415.4300
Cash Flow from Financing
  184   -14.1000   -81   -199.8000   204.5300
Decrease / Increase in Cash
  -97.6000   11.1000   40   -   -
Employees
  1,853   2,311   2,373   2,563   3,497